Skip to main content
This website uses cookies to ensure you get the best experience. By continuing to use this site, you agree to the use of cookies.

Please note: Your browser does not support the features used on Addgene's website. You may not be able to create an account or request plasmids through this website until you upgrade your browser. Learn more

Please note: Your browser does not fully support some of the features used on Addgene's website. If you run into any problems registering, depositing, or ordering please contact us at [email protected]. Learn more

Addgene

pGL2-Mcl-1 mut Citations (2)

Originally described in: Reduction of TRAIL-induced Mcl-1 and cIAP2 by c-Myc or sorafenib sensitizes resistant human cancer cells to TRAIL-induced death.
Ricci MS, Kim SH, Ogi K, Plastaras JP, Ling J, Wang W, Jin Z, Liu YY, Dicker DT, Chiao PJ, Flaherty KT, Smith CD, El-Deiry WS Cancer Cell. 2007 Jul . 12(1):66-80.
PubMed Journal

Articles Citing pGL2-Mcl-1 mut

Articles
Regulation of Mcl-1 by constitutive activation of NF-kappaB contributes to cell viability in human esophageal squamous cell carcinoma cells. Liu H, Yang J, Yuan Y, Xia Z, Chen M, Xie L, Ma X, Wang J, Ouyang S, Wu Q, Yu F, Zhou X, Yang Y, Cao Y, Hu J, Yin B. BMC Cancer. 2014 Feb 17;14:98. doi: 10.1186/1471-2407-14-98. PubMed
CCN3 overexpression inhibits growth of callosal projections via upregulation of RAB25. Park M, Baek IJ, Kim H, Woo DK, Park YJ, Shim S. Biochem Biophys Res Commun. 2015 Jun 5;461(3):456-62. doi: 10.1016/j.bbrc.2015.04.016. Epub 2015 Apr 12. PubMed

If you have published an article using this material, please email us at [email protected] to have your article added to this page.